Deep Intronic Mutation in SERPING1 Caused Hereditary Angioedema Through Pseudoexon Activation
P Hujová, P Souček, L Grodecká… - Journal of clinical …, 2020 - Springer
Purpose Hereditary angioedema (HAE) is a rare autosomal dominant life-threatening
disease characterized by low levels of C1 inhibitor (type I HAE) or normal levels of …
disease characterized by low levels of C1 inhibitor (type I HAE) or normal levels of …
Deep Intronic Mutation in SERPING1 Caused Hereditary Angioedema Through Pseudoexon Activation
P Hujová, P Souček, L Grodecká… - Journal of Clinical …, 2020 - is.muni.cz
Purpose Hereditary angioedema (HAE) is a rare autosomal dominant life-threatening
disease characterized by low levels of C1 inhibitor (type I HAE) or normal levels of …
disease characterized by low levels of C1 inhibitor (type I HAE) or normal levels of …
Deep Intronic Mutation in SERPING1 Caused Hereditary Angioedema Through Pseudoexon Activation.
P Hujová, P Souček, L Grodecká… - Journal of Clinical …, 2020 - europepmc.org
Purpose Hereditary angioedema (HAE) is a rare autosomal dominant life-threatening
disease characterized by low levels of C1 inhibitor (type I HAE) or normal levels of …
disease characterized by low levels of C1 inhibitor (type I HAE) or normal levels of …
Deep Intronic Mutation in SERPING1 Caused Hereditary Angioedema Through Pseudoexon Activation
P Hujová, P Souček, L Grodecká, H Grombiříková… - 2020 - muni.cz
Purpose Hereditary angioedema (HAE) is a rare autosomal dominant life-threatening
disease characterized by low levels of C1 inhibitor (type I HAE) or normal levels of …
disease characterized by low levels of C1 inhibitor (type I HAE) or normal levels of …
Deep Intronic Mutation in SERPING1 Caused Hereditary Angioedema Through Pseudoexon Activation.
P Hujová, P Souček, L Grodecká… - Journal of Clinical …, 2020 - search.ebscohost.com
Purpose: Hereditary angioedema (HAE) is a rare autosomal dominant life-threatening
disease characterized by low levels of C1 inhibitor (type I HAE) or normal levels of …
disease characterized by low levels of C1 inhibitor (type I HAE) or normal levels of …
Deep Intronic Mutation in SERPING1 Caused Hereditary Angioedema Through Pseudoexon Activation
P Hujová, P Souček, L Grodecká… - Journal of clinical …, 2020 - pubmed.ncbi.nlm.nih.gov
Purpose Hereditary angioedema (HAE) is a rare autosomal dominant life-threatening
disease characterized by low levels of C1 inhibitor (type I HAE) or normal levels of …
disease characterized by low levels of C1 inhibitor (type I HAE) or normal levels of …
Deep Intronic Mutation in SERPING1 Caused Hereditary Angioedema Through Pseudoexon Activation
P Hujová, P Souček, L Grodecká, H Grombiříková… - 2020 - med.muni.cz
Purpose Hereditary angioedema (HAE) is a rare autosomal dominant life-threatening
disease characterized by low levels of C1 inhibitor (type I HAE) or normal levels of …
disease characterized by low levels of C1 inhibitor (type I HAE) or normal levels of …
Deep Intronic Mutation in SERPING1 Caused Hereditary Angioedema Through Pseudoexon Activation
H Pavla, S Přemysl, G Lucie, G Hana… - Journal of Clinical …, 2020 - search.proquest.com
Purpose Hereditary angioedema (HAE) is a rare autosomal dominant life-threatening
disease characterized by low levels of C1 inhibitor (type I HAE) or normal levels of …
disease characterized by low levels of C1 inhibitor (type I HAE) or normal levels of …
Deep Intronic Mutation in SERPING1 Caused Hereditary Angioedema Through Pseudoexon Activation
P Hujová, P Souček, L Grodecká… - Journal of Clinical …, 2020 - is.muni.cz
Purpose Hereditary angioedema (HAE) is a rare autosomal dominant life-threatening
disease characterized by low levels of C1 inhibitor (type I HAE) or normal levels of …
disease characterized by low levels of C1 inhibitor (type I HAE) or normal levels of …
Deep Intronic Mutation in SERPING1 Caused Hereditary Angioedema Through Pseudoexon Activation
P Hujová, P Souček, L Grodecká, H Grombiříková… - 2020 - muni.cz
Purpose Hereditary angioedema (HAE) is a rare autosomal dominant life-threatening
disease characterized by low levels of C1 inhibitor (type I HAE) or normal levels of …
disease characterized by low levels of C1 inhibitor (type I HAE) or normal levels of …